Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1995-10-09 - 1995-10-31
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Study performed the OECD 420 fix dose method and Method B1 Annex V of 67/548/EEC

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1996
Report date:
1996

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.1 bis (Acute Oral Toxicity - Fixed Dose Procedure)
GLP compliance:
yes
Test type:
fixed dose procedure
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
3-oxo-4-azaandrost-5-ene-17β-carboxylic acid
EC Number:
407-830-6
EC Name:
3-oxo-4-azaandrost-5-ene-17β-carboxylic acid
Cas Number:
103335-54-2
Molecular formula:
Hill formula: C19H27NO3 CAS formula: C19H27NO3
IUPAC Name:
4a,6a-dimethyl-2-oxo-1H,2H,3H,4H,4aH,4bH,5H,6H,6aH,7H,8H,9H,9aH,9bH,10H-indeno[5,4-f]quinoline-7-carboxylic acid
Details on test material:
- Name of test material (as cited in study report): GR91287X
- Molecular formula (if other than submission substance): C19-H27-N-O3
- Molecular weight (if other than submission substance): 317.43
- Analytical purity: >95%
- Lot/batch No.: CO-0099
- Storage condition of test material: room temp in dark

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River (UK) Ltd
- Age at study initiation: 7 - 8 weeks
- Weight at study initiation: 188 -218g (males), 178-180g (females)
- Housing: 5 animals in solid floored polyporpylene cages with woodflakes
- Diet (e.g. ad libitum): Rat and Mouse expanded diet No.1, ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: at least 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-24°C
- Humidity (%): 50 - 55
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12

IN-LIFE DATES: From: 09.10.1995 To: 31.10.1995

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
arachis oil
Details on oral exposure:
VEHICLE
- Concentration in vehicle: 200 mg/ml
Doses:
Limit dose: 2000 mg/kg
No. of animals per sex per dose:
5 males 5 females
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations: at least daily
- Frequency of weighing: Day 0, 1, 2, 3, 7, 14
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight

Results and discussion

Preliminary study:
2 males and 2 females 500mg/kg (50mg/ml)
2 males and 2 females 2000mg/kg (200mg/ml)
Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
Mortality:
No animal died during the 14 day observation period.
Clinical signs:
other: Hunched posture was noted in all animals. Decreased respiratory rate was also noted in nine animals. All animals recovered one day ofter dosing.
Gross pathology:
No abnormlities were detected.

Applicant's summary and conclusion

Interpretation of results:
practically nontoxic
Remarks:
Migrated information Criteria used for interpretation of results: OECD GHS
Conclusions:
The LD50 (rat oral) of GR91287X is greater than 2000 mg/kg bw.
Executive summary:

The LD50 (rat oral) of GR91287X is greater than 2000 mg/kg bw. The experiment was performed as limit test with a concentration of 2000 mg/kg bw. No animal died during the 14 day observation period. No abnormalities were detected regarding body weight development or gross pathology. Hunched posture was noted in all animals. Decreased respiratory rate was also noted in nine animals. All animals recovered one day ofter dosing. The LD50 was determined to be greater than 2000 mg/kg bw.